Covered recipient · General Payments record
DAVID P YORK
Allopathic & Osteopathic Physicians Internal Medicine Pulmonary Disease
General Payments · PY2018–2020
$1,078.04
- Reported across 62 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2020 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $111.75 | 8 |
By paying entity
PY2020 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $56.48 | 4 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $14.99 | 1 |
| ADVANCED RESPIRATORY, INC | $14.83 | 1 |
| Mylan Specialty L.P. | $13.64 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $11.81 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2020 (8)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Advanced Respiratory, Inc | $14.83 | 01/14/2020 | Food and Beverage | Undisputed | 01/23/2026 | 751008503 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.93 | 02/11/2020 | Food and Beverage | Undisputed | 01/23/2026 | 736083535 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.65 | 06/23/2020 | Food and Beverage | Undisputed | 01/23/2026 | 735927677 | CMS |
| AstraZeneca Pharmaceuticals LP | $12.39 | 07/21/2020 | Food and Beverage | Undisputed | 01/23/2026 | 736312867 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.51 | 09/03/2020 | Food and Beverage | Undisputed | 01/23/2026 | 736015087 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $14.99 | 02/25/2020 | Food and Beverage | Undisputed | 01/23/2026 | 720479923 | CMS |
| Mylan Specialty L.P. | $13.64 | 01/28/2020 | Food and Beverage | Undisputed | 01/23/2026 | 751407757 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $11.81 | 03/09/2020 | Food and Beverage | Undisputed | 01/23/2026 | 747328337 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020
- Generated from
- OP_DTL_GNRL_PGYR2020_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.